Early haematologic response to anifrolumab in SLE: results from the European multicentre EFFORT-SLE study

Michela Gasparotto, Alessandra Bettiol, Ginevra De Marchi, Edoardo Biancalana, Giulia Duro, Filippo Fagni, Alice Horisberger, Joško Mitrović, Alessia Nano, Katarzyna Wawrzycka-Adamczyk, Myriam Reisch, Lea Salamon, Georg Schett, Ladislav Šenolt, Elena Silvestri, Jens Thiel, Paola Tomietto, Krzysztof Wójcik, Jakub Závada, Luca Quartuccio, Giacomo Emmi

Open source

DOI: 10.1093/rheumatology/keag400
Published: 2026-08-11
Container: Rheumatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag400,
  title = {Early haematologic response to anifrolumab in SLE: results from the European multicentre EFFORT-SLE study},
  author = {Michela Gasparotto and Alessandra Bettiol and Ginevra De Marchi and Edoardo Biancalana and Giulia Duro and Filippo Fagni and Alice Horisberger and Joško Mitrović and Alessia Nano and Katarzyna Wawrzycka-Adamczyk and Myriam Reisch and Lea Salamon and Georg Schett and Ladislav Šenolt and Elena Silvestri and Jens Thiel and Paola Tomietto and Krzysztof Wójcik and Jakub Závada and Luca Quartuccio and Giacomo Emmi},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keag400},
  url = {https://doi.org/10.1093/rheumatology/keag400}
}

RIS

TY  - JOUR
TI  - Early haematologic response to anifrolumab in SLE: results from the European multicentre EFFORT-SLE study
AU  - Michela Gasparotto
AU  - Alessandra Bettiol
AU  - Ginevra De Marchi
AU  - Edoardo Biancalana
AU  - Giulia Duro
AU  - Filippo Fagni
AU  - Alice Horisberger
AU  - Joško Mitrović
AU  - Alessia Nano
AU  - Katarzyna Wawrzycka-Adamczyk
AU  - Myriam Reisch
AU  - Lea Salamon
AU  - Georg Schett
AU  - Ladislav Šenolt
AU  - Elena Silvestri
AU  - Jens Thiel
AU  - Paola Tomietto
AU  - Krzysztof Wójcik
AU  - Jakub Závada
AU  - Luca Quartuccio
AU  - Giacomo Emmi
PY  - 2026
JO  - Rheumatology
DO  - 10.1093/rheumatology/keag400
UR  - https://doi.org/10.1093/rheumatology/keag400
ER  -

APA

Gasparotto, M., Bettiol, A., Marchi, G. D., Biancalana, E., Duro, G., Fagni, F., Horisberger, A., Mitrović, J., Nano, A., Wawrzycka-Adamczyk, K., Reisch, M., Salamon, L., Schett, G., Šenolt, L., Silvestri, E., Thiel, J., Tomietto, P., Wójcik, K., Závada, J., Quartuccio, L., & Emmi, G. (2026). Early haematologic response to anifrolumab in SLE: results from the European multicentre EFFORT-SLE study. Rheumatology. https://doi.org/10.1093/rheumatology/keag400

Source records

crossref · retrieved 2026-09-26T08:39:13.270Z